Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vera Therapeutics (NASDAQ:VERA)

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vera Therapeutics (NASDAQ:VERA)

BRISBANE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA) today announced that on April 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 211,250 shares of Class A common stock and restricted stock units (RSUs) for 105,125 shares of Class A common stock to sixteen (16) new employees under the Inducement Plan. The Compensation Committee approved the…

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $64.67 Average Price Target from Analysts

Shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) have earned a consensus rating of “Buy” from the ten ratings firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating, six have issued a buy rating and three have issued a strong buy rating […]